derinet® Switzerland
Back

17.50% p.a. Barrier Reverse Convertible on BioNTech, Moderna, Novavax (Quanto CHF)

  • Valor 59516191
  • ISIN CH0595161917
  • Symbol RMBLOV
Bid (indicative)%
Nominal
Ask (indicative)%
Nominal
CurrencyCHF
Price on
Sell
Buy
  • Quanto
  • (Issuer) Callable
Moderna Inc.USD 
BioNTech SEUSD 
Novavax Inc.USD 
Please note that this is an indication.

Documents

Key data
Yield max.21.61%
Yield max. p.a.23.63%
Barrier reachedno
Interest
Coupon (Coupon p.a.)17.50% (17.50%)
Premium component17.5000%
Interest share0.00%
Day count convention30/360
Pricingdirty
Life cycle
Initial fixing25/06/2021
First Trading Day01/07/2021
Payment date02/07/2021
Final fixing27/06/2022
Redemption04/07/2022

Current price information

Intraday1 week1 monthSince emission
until
Product Underlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
USD 340.21USD 230.02USD 115.01
USD 346.61USD 219.94USD 109.97
USD 182.72USD 189.79USD 94.90

No chart available

Key data
Yield max.21.61%
Yield max. p.a.23.63%
Barrier reachedno
Interest
Coupon (Coupon p.a.)17.50% (17.50%)
Premium component17.5000%
Interest share0.00%
Day count convention30/360
Pricingdirty
Life cycle
Initial fixing25/06/2021
First Trading Day01/07/2021
Payment date02/07/2021
Final fixing27/06/2022
Redemption04/07/2022
Figures
SSPA categorisationBarriere Reverse Convertible
Issue price100.00%
Nominal valueCHF 1,000.00
Reference currencyCHF
QuantoYes
Strike price

Reference price of the underlying used to calculate the cash settlement on expiry of the warrant. In cases of physical delivery it is the price at which the underlying is bought (call) or sold (put). Also called: exercise price

100.00%
Barrier50.00%
Barrier observationcontinuous
ListingSIX Structured Products Exchange
Additional conditions
IssuerBank Vontobel AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliverycash payment
Issuance ProgrammeLink to the Issuance Program